Journal of Basic and Clinical Pathophysiology

Journal of Basic and Clinical Pathophysiology

Effect of apigenin on endothelium-dependent relaxation of aorta in streptozotocin-induced diabetic rats

Document Type : Research Paper

Authors
Mohamadreza Rajabi 1
Mehrdad Roghani 2
Iman Ansari 3
Elahe Rashidi 4
Elnaz Babakhani 5
Saba Ansari 6
1 Department of Cardiology, Faculty of Medicine, Shahed University, Tehran, Iran.
2 Neurophysiology Research Center, Shahed University, Tehran, Iran
3 Medical Students Research Committee, Shahed University, Tehran, Iran
4 Faculty of Medicine, Shahed University, Tehran, Iran
5 Medical Students Scientific Association, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
6 Department of Cellular and Molecular Biology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
10.22070/jbcp.2021.15168.1150
Abstract
Objective: The current study aimed at evaluating the effect of flavonoid apigenin on contractile response and relaxation of aorta in streptozotocin (STZ)-induced diabetic rats.
Materials and Methods: Thirty-two rats were randomly divided into four groups of control, apigenin, diabetic (DM), and DM + apigenin. DM was induced in rats using intraperitoneal (i.p.) injection of STZ at 60 mg/kg. The two treatment groups received apigenin at a dose of 10 mg/kg i.p. every other day for four weeks. At the end of the study, the contractile responses of aorta to potassium chloride (KCL), phenylephrine (PE), and the relaxation response of the aorta to acetylcholine (ACh) were measured.
Results: Treatment with apigenin significantly reduced plasma glucose in diabetic rats in the 2nd and 4th weeks as compared to those of the DM group (P = 0.01). The DM+apigenin group had less contractile response as compared to that of the DM group, although the difference was not statistically significant (P >0.05). Treatment of diabetic rats with apigenin could significantly reduce the maximum contractile response as compared to that of the DM group (P = 0.05). The contractile response to ACh was significantly higher in the DM + apigenin group as compared to that of the DM group (P = 0.05).
Conclusion: The results of the current study indicated the hypoglycemic effects of apigenin in diabetic rats. In addition, it was observed that the administration of apigenin to diabetic and healthy rats could reduce contractile response of aorta to PE and increase the relaxation response to ACh.
Keywords
Apigenin
Diabetes mellitus
Aorta
Streptozotocin
Endothelium
  1. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice 2018;138:271-281. doi: 10.1016/j.diabres.2018.02.023.
  2. Vrsalovic M, Vucur K, Vrsalovic Presecki A, Fabijanic D, Milosevic M. Impact of diabetes on mortality in peripheral artery disease: a meta-analysis. Clinical Cardiology 2017;40(5):287-291. doi: 10.1002/clc.22657.
  3. Ghosian Moghadam MH, Ansari I, Roghani M, Ghanem A, Mehdizade N. The Effect of Oral Administration of Hypericum Perforatum on Serum Glucose and Lipids, Hepatic Enzymes and Lipid Peroxidation in Streptozotocin-Induced Diabetic Rats. Galen Medical Journal 2017; 6(4):319-329. doi: 10.22086/gmj.v6i4.889
  4. Fallahi F, Roghani M, Ansari I. The effect of hydroalcoholic extract of Cydonia oblonga Miller leaf on doxorubicin-induced cardiac injury in rat. Journal of Basic and Clinical Pathophysiology 2018;6(2):7-12. doi: 10.22070/jbcp.2018.3215.1096
  5. Malik S, Suchal K, Khan SI, Bhatia J, Kishore K, Dinda AK, Arya DS. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways. American Journal of Physiology-Renal Physiology 2017;313(2):F414-F422. doi: 10.1152/ajprenal.00393.2016.
  6. Ren B, Qin W, Wu F, Wang S, Pan C, Wang L, et al. Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. European Journal of Pharmacology 2016 ;773:13-23. doi: 10.1016/j.ejphar.2016.01.002.
  7. Qin W, Ren B, Wang S, Liang S, He B, Shi X, et al. Apigenin and naringenin ameliorate PKCβII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high glucose. Vascular Pharmacology 2016;85:39-49. doi: 10.1016/j.vph.2016.07.006.
  8. Mahajan UB, Chandrayan G, Patil CR, Arya DS, Suchal K, Agrawal YO, et al. The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway. International Journal of Molecular 2017;18(4). pii: E756. doi: 10.3390/ijms18040756.
  9. Liu HJ, Fan YL, Liao HH, Liu Y, Chen S, Ma ZG, et al. Apigenin alleviates STZ-induced diabetic cardiomyopathy. Molecular and Cellular Biochemistry 2017;428(1-2):9-21. doi: 10.1007/s11010-016-2913-9.
  10. Jin BH, Qian LB, Chen S, Li J, Wang HP, Bruce IC, et al. Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. European Journal of Pharmacology 2009 ;616(1-3):200-5. doi: 10.1016/j.ejphar.2009.06.020.
  11. Sui H, Zhi Y, Liu H, Gao P, Xu H, Yan W. Endothelium-dependent vasorelaxation effects induced by apigenin on the thoracic aorta of rats and its possible mechanism. Wei Sheng Yan Jiu 2011;40(4):416-9, 422.
  12. Fallahi F, Roghani M, Moghadami S. Citrus flavonoid naringenin improves aortic reactivity in streptozotocin-diabetic rats. Indian Journal of Pharmacology 2012;44(3):382-6. doi: 10.4103/0253-7613.96350
  13. Mahdavi MR, Roghani M, Baluchnejadmojarad T. Mechanisms responsible for the vascular effect of aqueous Trigonella foenum-graecum leaf extract in diabetic rats. Indian Journal of Pharmacology 2008;40(2):59-63. doi: 10.4103/0253-7613.41039
  14. Qian LB, Fu JY, Cai X, Xia ML. Betulinic acid inhibits superoxide anion-mediated impairment of endothelium-dependent relaxation in rat aortas. Indian Journal of Pharmacology 2012;44(5):588-92. doi: 10.4103/0253-7613.100382.
  15. Pennathur S, Heinecke JW. Oxidative stress and endothelial dysfunction in vascular disease. Current Diabetes Reports 2007;7(4):257-64.
  16. Suh KS, Oh S, Woo JT, Kim SW, Kim JW, Kim YS, et al. Apigenin attenuates 2-deoxy-D-ribose-induced oxidative cell damage in HIT-T15 pancreatic β-cells. Biological and Pharmaceutical Bulletin 2012;35(1):121-6.
  17. Wang N, Yi WJ, Tan L, Zhang JH, Xu J, Chen Y, et al. Apigenin attenuates streptozotocin-induced pancreatic β cell damage by its protective effects on cellular antioxidant defense. In Vitro Cellular & Developmental Biology 2017;53(6):554-563. doi: 10.1007/s11626-017-0135-4.
  18. Yamagata K, Miyashita A, Matsufuji H, Chino M. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells. Journal of Nutritional Biochemistry 2010;21(2):116-24. doi: 10.1016/j.jnutbio.2008.11.003.
Journal of Basic and Clinical Pathophysiology
Volume 9, Issue 2
November 2021
Pages 15-21